GlaxoSmithKline drags FTSE down

clock

GlaxoSmithKline was the biggest drag on the FTSE which fell in early trading as oil companies also dropped.

The FTSE 100 Index was down 0.7% to 6561.30 while the FTSE All-Share Index also fell 0.7% to 3408.98. The 2.5% fall for Glaxo was attributable to Merrill Lynch lowering its recommendation on the shares from neutral to sell. Meanwhile, BP and Royal Dutch Shell dropped 0.6pc and 0.9% respectively. Another notable fall was Standard Life Plc which lost 2.75 pence, or 0.8 percent, to 337.25. Its shares were rated `underweight by JPMorgan Chase & Co. as the bank believes Standard Life is currently overvalued based on the prospects for the SIPP market, which it feels are likely to dwindle. ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Economics / Markets

OBR independence 'a major advantage' for UK economy

OBR independence 'a major advantage' for UK economy

Treasury Committee hearing

Alex Sebastian
clock 20 May 2026 • 4 min read
Bank of England warns of future rate uncertainty after vote to hold at 3.75%

Bank of England warns of future rate uncertainty after vote to hold at 3.75%

One vote to hike rates

Michael Nelson
clock 30 April 2026 • 2 min read
Navigating an uncertain environment: Applying a disciplined, data-driven approach

Navigating an uncertain environment: Applying a disciplined, data-driven approach

'​Looking ahead, the fundamental case remains constructive'

Fahad Hassan
clock 28 April 2026 • 2 min read